Preterm Birth and PROM Testing Market to Grow at 8.61% CAGR over 2025 to 2029

According to TechSci Research report, “Preterm Birth and PROM Testing Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2019-2029F”, the Global Preterm Birth and PROM Testing Market stood at USD 1.08 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 8.61% through 2029. The global preterm birth and PROM (Premature Rupture of Membranes) testing market is influenced by a variety of factors. Rising incidences of preterm births globally, advancements in medical technology, and increased focus on prenatal testing and neonatal care are key drivers.

Additionally, government initiatives for improving maternal health and growing awareness about preterm birth risks and diagnostic solutions also contribute to market growth.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Preterm Birth and PROM Testing Market”

The global Preterm Birth and Premature Rupture of Membranes (PROM) Testing market is witnessing significant growth, primarily driven by the increasing prevalence of preterm births and the rising awareness about maternal-fetal health. The necessity for early detection and proper management of preterm births and PROM has led to the upsurge in demand for effective testing solutions. This has propelled the development of innovative and advanced technologies, resulting in a highly competitive market.

The market for preterm birth and PROM testing is expected to further expand in the coming years, driven by advancements in medical technology and growing government initiatives towards maternal and child healthcare. In addition, favorable reimbursement policies and insurance coverage for these tests are also contributing to the market growth.

Furthermore, increasing investments by key players in research and development activities are leading to the introduction of new and improved diagnostic tools and techniques for preterm birth and PROM testing. This is further fueling the market growth.

Moreover, the growing trend of personalized medicine and precision diagnostics is also expected to boost the demand for specialized testing solutions for preterm birth and PROM. These advancements in technology are allowing for more accurate and timely diagnosis, enabling better management of preterm births and PROM. Moreover, the market is witnessing strategic collaborations between key players and various research institutes to accelerate the development of advanced testing solutions. For instance, in 2020, Hologic Inc. partnered with the University of Utah Health Sciences Center to develop a novel PROM test.

Despite the promising growth, the Preterm Birth and PROM Testing market faces certain challenges, including the high cost of testing, limited awareness in developing regions, and the lack of trained professionals. However, the increasing focus on maternal-fetal health, coupled with technological advancements in testing procedures, is expected to overcome these challenges and propel the market further. The Global Preterm Birth and PROM Testing Market is poised for substantial growth in the coming years. This growth is primarily driven by the increasing prevalence of preterm births, rising awareness about maternal health, and technological advancements in testing solutions. However, to ensure sustainable growth, there is a pressing need to address existing challenges such as high testing costs and limited awareness in certain regions.

The Global Preterm Birth and PROM Testing Market is segmented into test type, application, regional distribution, and company

Based on application, Premature Rupture of Membranes (PROM) holds a prominent position in the Global Preterm Birth and PROM Testing Market. This dominance is primarily attributed to the substantial increase in the incidence of PROM worldwide. PROM, an obstetric complication, often leads to preterm births, necessitating a high demand for early diagnosis and effective management strategies. Moreover, the continuous advancements in diagnostic technologies have revolutionized the early detection of PROM, providing more accurate and rapid diagnosis methods. This, in turn, contributes significantly to the growth and expansion of the global market. As the need for managing and preventing PROM remains consistent, its dominant position in the market is further reinforced.

Based on region, North America is at the forefront of the Global Preterm Birth and Premature Rupture of Membranes (PROM) Testing Market, and this can be attributed to a multitude of factors. Firstly, the region boasts advanced healthcare infrastructure, equipped with state-of-the-art facilities and cutting-edge technology. This allows for accurate and efficient testing, ensuring optimal healthcare outcomes for patients. Furthermore, North America exhibits higher healthcare spending compared to other regions, which enables the implementation of comprehensive healthcare programs and services. This investment in healthcare translates to enhanced access to PROM testing, ensuring that individuals receive timely and appropriate medical attention. In addition, the region is home to a strong presence of leading market players, including prominent healthcare providers, research institutions, and diagnostic companies. These entities collaborate and innovate to develop and offer advanced PROM testing solutions, driving the market's growth and fostering continuous improvement in healthcare delivery.

Moreover, the escalating rate of women opting for late pregnancies in North America has contributed to the increased demand for PROM testing. As more women choose to start families later in life, there is a heightened need for comprehensive prenatal care, including early detection and monitoring of potential complications such as PROM. This trend, coupled with the region's emphasis on proactive healthcare practices, has bolstered the market's expansion. Increased awareness about the benefits of early diagnosis and preventive care has played a significant role in promoting the adoption of PROM testing in North America. The region's healthcare initiatives prioritize education and public awareness campaigns, empowering individuals to take proactive measures in managing their health. This heightened awareness has led to a greater understanding of the importance of early detection and intervention, driving the demand for PROM testing services.

Major companies operating in Global Preterm Birth and PROM Testing Market are:

• Qiagen N.V.
• Hologic, Inc.
• Cooper Surgical Inc.
• Abbott Laboratories Inc.
• Medix Biochemica Oy AB
• Sera Prognostics Inc.
• Clinical Innovations, LLC
• Biosynex
• NX Prenatal, Inc.
• IQ Products Co.

Download Free Sample Report

Customers can also request for 10% free customization on this report

“Global Preterm Birth and PROM Testing Market is rapidly evolving, with significant advancements in testing technology and an increasing number of awareness campaign for preterm birth for making people aware about the impact of premature birth of baby. The market is dominated by Ultrasound segment, ultrasound segment has the high accuracy and reliability of ultrasound testing, as well as its widespread availability in healthcare settings. There is also a growing focus on non-invasive testing methods these methods reduce discomfort for pregnant women with accurate and reliable results. Technological advancements, such as the genetic testing there is ongoing research for genetic markers and perform genetic testing, are also driving the development of more effective testing. Additionally, there is a growing emphasis on the need for personalized medications The field of preterm birth and PROM testing is moving towards personalized medicine approaches. Through this tailored diagnostic can be done and patients specific treatment should be given. The increasing number of awareness campaign and partnerships between public and private sectors bodes well for the future of the Preterm Birth And PROM Testing market, with several promising candidates currently in advanced stages of development.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Preterm Birth And PROM Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented By Test Type (Pelvic Exam, Ultrasound, Biochemical Markers {Interleukin (IL)-6, C-Reactive Protein (CRP), IL-1, IL-2, IL-8, TNF-a, Corticotropin-Releasing Hormone (CRH), Alpha-fetoprotein (AFP)}, Uterine Monitoring, Nitazine Test, Ferning Test, Pooling, PAMG-1 Immunoassay, IGFBP Test, Fetal Fibronectin, Others), By Application (PROM, Preterm Labor, Chorioamnionitis), By Region and Competition”, has evaluated the future growth potential of Global Preterm Birth and PROM Testing Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Preterm Birth and PROM Testing Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com